Medicines and Legal Notices




NEW ZEALAND GAZETTE, No. 49 — 11 MAY 2017

Schedule

Product: Avastin
Active Ingredient: Bevacizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturers: Genentech Inc, California, United States of America
Genentech Inc, Oregon, United States of America
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
F Hoffmann-La Roche Limited, Basel, Switzerland
Roche Diagnostics GmbH, Mannheim, Germany

Dated this 5th day of May 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2017-go2205

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Rilutek
Active Ingredient: Riluzole 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Sanofi-Aventis New Zealand Limited
Manufacturer: Sanofi Winthrop Industrie, Compiegne, France

Note: This consent is given subject to the following conditions:

Rilutek can only be prescribed by specialist physicians who care for patients with Motor Neurone Disease, neurologists and palliative care physicians. Rilutek Tablets can only be used by patients with vital capacity greater than 60%.

Also note: This consent is valid for two years from the date of publication of this notice.

Dated this 5th day of May 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2017-go2206

Notification of Additions to the Generally Recognised as Safe List (Notice No. MPI 751A)

Pursuant to section 8B(5) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), substances generally recognised as safe and exempt from registration under Part 2 of the Act have been added to the Generally Recognised as Safe List (“List”).

A copy of the List may be inspected free of charge at or purchased from the office of the Ministry for Primary Industries, Pastoral House, 25 The Terrace (PO Box 2526), Wellington.

Dated at Wellington this 2nd day of May 2017.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).

2017-go2219

Court of Trial Protocol Established by the Chief High Court Judge and the Chief District Court Judge for Category 2 and 3 Offences Pursuant to Section 66 of the Criminal Procedure Act 2011

36



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 49





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a New Medicine (Avastin)

🏥 Health & Social Welfare
5 May 2017
Medicine, Distribution, Avastin, Bevacizumab, Medicines Act 1981
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health

🏥 Provisional Consent to the Distribution of a New Medicine (Rilutek)

🏥 Health & Social Welfare
5 May 2017
Medicine, Distribution, Rilutek, Riluzole, Medicines Act 1981
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health

🌾 Notification of Additions to the Generally Recognised as Safe List

🌾 Primary Industries & Resources
2 May 2017
Agricultural Compounds, Veterinary Medicines, Generally Recognised as Safe List
  • MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries

⚖️ Court of Trial Protocol Established for Category 2 and 3 Offences

⚖️ Justice & Law Enforcement
Court Protocol, Criminal Procedure Act 2011, Category 2 and 3 Offences